{"id":"matching-placebo-nasal-spray","safety":{"commonSideEffects":[]},"_chembl":null,"_fixedAt":"2026-03-30T17:15:25.912236","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Matching placebo nasal sprays are inert formulations designed to mimic the appearance, taste, smell, and administration route of an active investigational drug while containing no therapeutic agent. They are used in blinded clinical trials to control for placebo effect and ensure valid efficacy and safety comparisons between treatment and control groups.","oneSentence":"A placebo nasal spray formulation containing no active pharmaceutical ingredient, used as a control comparator in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:20:16.149Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"_fixedFields":["pubmed(6)"],"trialDetails":[{"nctId":"NCT06850805","phase":"PHASE3","title":"Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps","status":"RECRUITING","sponsor":"Optinose US Inc.","startDate":"2025-07-28","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":84},{"nctId":"NCT06834347","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-12","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT06834360","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-06","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT06954428","phase":"PHASE1","title":"Clinical Trial of Intranasal Delivery of NT-301","status":"COMPLETED","sponsor":"Nano PharmaSolutions Australia","startDate":"2025-06-20","conditions":"Tolerability of NT-301 Nasal Spray, Pharmacokinetics of NT-301 Nasal Spray, Safety of NT-301 Nasal Spray","enrollment":49},{"nctId":"NCT07398612","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-01-31","conditions":"Acute Ischemic Stroke","enrollment":60},{"nctId":"NCT07304518","phase":"PHASE2","title":"Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults","status":"RECRUITING","sponsor":"Sichuan Purity Pharmaceutical Technology Co., Ltd.","startDate":"2026-01-26","conditions":"Migraine","enrollment":456},{"nctId":"NCT07000877","phase":"PHASE4","title":"Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.","status":"RECRUITING","sponsor":"Telethon Kids Institute","startDate":"2025-06-25","conditions":"Perioperative Respiratory Adverse Events, Anesthesia Outcomes","enrollment":200},{"nctId":"NCT06691113","phase":"PHASE2","title":"A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-12-16","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":60},{"nctId":"NCT06013241","phase":"PHASE2","title":"A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)","status":"COMPLETED","sponsor":"Insmed Incorporated","startDate":"2023-10-30","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":288},{"nctId":"NCT07189572","phase":"PHASE3","title":"Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-10","conditions":"Otitis Media, Otitis Media With Effusion After Nasopharyngeal Carcinoma, Radiotherapy Side Effects","enrollment":168},{"nctId":"NCT05878093","phase":"PHASE3","title":"Dupilumab in Chinese Adult Participants With CRSwNP","status":"COMPLETED","sponsor":"Sanofi","startDate":"2023-05-16","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":63},{"nctId":"NCT03608163","phase":"PHASE4","title":"Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)","status":"TERMINATED","sponsor":"Albert Einstein College of Medicine","startDate":"2019-01-08","conditions":"Diabetes Mellitus, Type 1, Hypoglycemia, Hypoglycemia Unawareness","enrollment":4},{"nctId":"NCT07103915","phase":"NA","title":"Intranasal Lidocaine Spray Versus Nasogastric Tube Administration in the Emergency Room","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2023-11-01","conditions":"Nasogasrtic Tube Insertion","enrollment":120},{"nctId":"NCT04870333","phase":"PHASE2, PHASE3","title":"PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V","status":"COMPLETED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2021-02-19","conditions":"Covid19","enrollment":2240},{"nctId":"NCT04051619","phase":"PHASE1","title":"Oxytocin, Stress, Craving, Opioid Use Disorder","status":"COMPLETED","sponsor":"Brown University","startDate":"2020-01-06","conditions":"Opioid Use Disorder","enrollment":20},{"nctId":"NCT02133001","phase":"PHASE2","title":"A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2014-05-23","conditions":"Major Depressive Disorder","enrollment":68},{"nctId":"NCT03852160","phase":"PHASE3","title":"A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression","status":"WITHDRAWN","sponsor":"Janssen-Cilag International NV","startDate":"2019-12-01","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":""},{"nctId":"NCT04599855","phase":"PHASE4","title":"A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-11-04","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":477},{"nctId":"NCT06036927","phase":"PHASE2","title":"A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-12-08","conditions":"Chronic Sinusitis, Nasal Polyps","enrollment":80},{"nctId":"NCT04596189","phase":"PHASE4","title":"Dupilumab for Prevention of Recurrence of CRSwNP After ESS","status":"COMPLETED","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2021-05-25","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":30},{"nctId":"NCT00070707","phase":"PHASE4","title":"Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-04-03","conditions":"Rhinitis, Allergic, Seasonal, Asthma","enrollment":188},{"nctId":"NCT00732381","phase":"PHASE3","title":"Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-08","conditions":"Allergic Rhinitis","enrollment":351},{"nctId":"NCT00733005","phase":"PHASE3","title":"Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-07","conditions":"Allergic Rhinitis","enrollment":324},{"nctId":"NCT01386125","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-06","conditions":"Nasal Polyps","enrollment":748},{"nctId":"NCT00423176","phase":"PHASE3","title":"The Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2006-12","conditions":"Sinusitis","enrollment":237},{"nctId":"NCT00552110","phase":"PHASE2","title":"Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-07","conditions":"Seasonal Allergic Rhinitis","enrollment":707},{"nctId":"NCT05180500","phase":"PHASE1","title":"Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis","status":"COMPLETED","sponsor":"Sharon Hillier","startDate":"2022-03-15","conditions":"COVID-19, Pharmacokinetics, Safety","enrollment":50},{"nctId":"NCT06063330","phase":"PHASE1","title":"Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects","status":"COMPLETED","sponsor":"Red Queen Therapeutics, Inc.","startDate":"2023-09-27","conditions":"COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed","enrollment":66},{"nctId":"NCT05768113","phase":"","title":"LAEH Formulation Nasal Spray to Reduce Viral Load","status":"COMPLETED","sponsor":"Salvacion USA Inc.","startDate":"2021-05-29","conditions":"Coronavirus Disease","enrollment":30},{"nctId":"NCT04713826","phase":"PHASE2","title":"A Trial to Learn More About How Well BAY2586116 Works and How Safe it is in Participants With Moderate to Severe Obstructive Sleep Apnea","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-03-03","conditions":"Sleep Apnea, Obstructive","enrollment":93},{"nctId":"NCT04236440","phase":"PHASE2","title":"Study on the Safety of Drug BAY2586116 and How it Works in Patients With Obstructive Sleep Apnea (a Sleep Disorder Caused by the Narrowing and Collapse of the Airway During Sleep) Including the Blood Level of the Drug and Effect of Its Doses and Routes of Administration","status":"COMPLETED","sponsor":"Bayer","startDate":"2020-02-04","conditions":"Sleep Apnea, Obstructive","enrollment":14},{"nctId":"NCT03046836","phase":"PHASE2","title":"Oxytocin, Alcohol Craving, and Intimate Partner Aggression","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2017-07-01","conditions":"Alcohol Use","enrollment":200},{"nctId":"NCT03688555","phase":"PHASE2","title":"A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-10-19","conditions":"Bilateral Nasal Polyposis","enrollment":10},{"nctId":"NCT04264637","phase":"PHASE3","title":"Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis","status":"COMPLETED","sponsor":"Bayer","startDate":"2020-02-03","conditions":"Allergic Rhinitis","enrollment":110},{"nctId":"NCT04932915","phase":"PHASE2","title":"Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19","status":"TERMINATED","sponsor":"UNION therapeutics","startDate":"2021-09-03","conditions":"Covid19","enrollment":4},{"nctId":"NCT03882047","phase":"PHASE3","title":"Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1994-08-11","conditions":"Rhinitis, Allergic, Seasonal","enrollment":313},{"nctId":"NCT03879772","phase":"PHASE3","title":"Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1996-03-12","conditions":"Rhinitis, Allergic, Seasonal","enrollment":679},{"nctId":"NCT00728416","phase":"PHASE3","title":"Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-08","conditions":"Allergic Rhinitis","enrollment":333},{"nctId":"NCT00358527","phase":"PHASE4","title":"Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-05","conditions":"Seasonal Allergic Rhinitis","enrollment":401},{"nctId":"NCT03401229","phase":"PHASE3","title":"Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2018-01-15","conditions":"Nasal Polyposis","enrollment":413},{"nctId":"NCT03085797","phase":"PHASE3","title":"Effect of Mepolizumab in Severe Bilateral Nasal Polyps","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-05-25","conditions":"Nasal Polyps","enrollment":414},{"nctId":"NCT02856802","phase":"PHASE2","title":"An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)","status":"COMPLETED","sponsor":"Upsher-Smith Laboratories","startDate":"2016-07-11","conditions":"Migraine Headaches","enrollment":107},{"nctId":"NCT04132570","phase":"PHASE4","title":"A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division","startDate":"2019-10-22","conditions":"Rhinitis","enrollment":206},{"nctId":"NCT02424539","phase":"PHASE4","title":"A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-09-30","conditions":"Rhinitis, Allergic, Perennial and Seasonal, Rhinitis, Allergic","enrollment":358},{"nctId":"NCT03280550","phase":"PHASE3","title":"A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2017-11-15","conditions":"Nasal Polyps, Chronic Rhinosinusitis","enrollment":138},{"nctId":"NCT03280537","phase":"PHASE3","title":"A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2017-11-21","conditions":"Nasal Polyps, Chronic Rhinosinusitis","enrollment":127},{"nctId":"NCT02898454","phase":"PHASE3","title":"Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-11-28","conditions":"Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)","enrollment":448},{"nctId":"NCT00884897","phase":"PHASE2","title":"Oxytocin and Social Cognition in Schizophrenia","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2010-01","conditions":"Social Cognition, Social Anxiety, Emotional Intelligence","enrollment":28},{"nctId":"NCT01752712","phase":"NA","title":"Oxytocin and CBSST for People With Schizophrenia","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2014-01","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":83},{"nctId":"NCT01963078","phase":"PHASE2","title":"Sex/Gender Differences in Risk and Resilience to PTSD; Implication of Oxytocin","status":"COMPLETED","sponsor":"Megan Moran-Santa Maria","startDate":"2013-04","conditions":"PTSD","enrollment":38},{"nctId":"NCT02671266","phase":"PHASE2","title":"Oxytocin Administration in BDD and OCD","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2014-12","conditions":"Body Dysmorphic Disorder, Obsessive-compulsive Disorder","enrollment":41},{"nctId":"NCT01916226","phase":"PHASE4","title":"A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-08-01","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":682},{"nctId":"NCT01963091","phase":"PHASE2","title":"Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2011-07","conditions":"Cocaine Dependence","enrollment":33},{"nctId":"NCT03238924","phase":"PHASE2","title":"Prolonged Exposure and Oxytocin","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2015-01-01","conditions":"PTSD","enrollment":17},{"nctId":"NCT01856530","phase":"PHASE1, PHASE2","title":"Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder","status":"COMPLETED","sponsor":"Stefan G. Hofmann","startDate":"2012-07","conditions":"Social Anxiety Disorder","enrollment":60},{"nctId":"NCT00400998","phase":"PHASE2","title":"Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Research Consult GmbH","startDate":"2006-03","conditions":"Allergic Rhinitis, Rhinitis, Allergic, Seasonal","enrollment":41},{"nctId":"NCT02569437","phase":"PHASE2","title":"Doxycycline in Treating Patients With Chronic Rhinosinusitis With Nasal Polyps","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2014-09","conditions":"Polyp of Nasal Sinus","enrollment":49},{"nctId":"NCT00404586","phase":"PHASE1","title":"Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-09-11","conditions":"Rhinitis, Allergic, Perennial","enrollment":45},{"nctId":"NCT00972504","phase":"PHASE2","title":"723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-06-01","conditions":"Rhinitis, Allergic, Seasonal","enrollment":54},{"nctId":"NCT03228901","phase":"PHASE2","title":"Oxytocin and Non-verbal Communication","status":"COMPLETED","sponsor":"Yale-NUS College","startDate":"2007-01","conditions":"Social Interaction","enrollment":104},{"nctId":"NCT03198676","phase":"PHASE1","title":"A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production","status":"COMPLETED","sponsor":"Prep Biopharm Limited","startDate":"2017-05-08","conditions":"Upper Respiratory Tract Infections","enrollment":20},{"nctId":"NCT01466127","phase":"NA","title":"The Effect of Oxytocin on Fear Memory Consolidation Novel Intervention to Prevent Posttraumatic Stress Disorder (PTSD)","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2011-10","conditions":"Posttraumatic Stress Disorder","enrollment":60},{"nctId":"NCT00730756","phase":"PHASE2","title":"A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-03","conditions":"Rhinitis, Allergic, Perennial","enrollment":102},{"nctId":"NCT00562159","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":439},{"nctId":"NCT00550550","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":345},{"nctId":"NCT02155881","phase":"PHASE3","title":"Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-08","conditions":"Seasonal Allergic Rhinitis","enrollment":80},{"nctId":"NCT01827332","phase":"NA","title":"Effect of Oxytocin on Craving and Therapy Response","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2013-03","conditions":"Marijuana Dependence","enrollment":16},{"nctId":"NCT00539006","phase":"PHASE4","title":"Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-08","conditions":"Rhinitis, Allergic, Perennial","enrollment":377},{"nctId":"NCT00519636","phase":"PHASE4","title":"Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-08","conditions":"Rhinitis, Allergic, Perennial","enrollment":360},{"nctId":"NCT01075789","phase":"NA","title":"Using Lignocaine Spray and Gel to Reduce the Pain Associated With Nasogastric Tube Insertion in Children","status":"TERMINATED","sponsor":"The University of Queensland","startDate":"2010-05","conditions":"Intubation; Difficult","enrollment":13},{"nctId":"NCT01551303","phase":"NA","title":"Effect of Intranasal Neuropeptide on Emotion Perception in Trait Anxiety","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-02","conditions":"Social Intelligence","enrollment":47},{"nctId":"NCT00803686","phase":"PHASE2","title":"A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women","status":"COMPLETED","sponsor":"Tarsa Therapeutics, Inc.","startDate":"2008-12","conditions":"Phase 1 Pharmacodynamic Study","enrollment":12},{"nctId":"NCT01429051","phase":"PHASE3","title":"A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain","status":"COMPLETED","sponsor":"Takeda","startDate":"2011-08","conditions":"Break Through Pain, Cancer","enrollment":46},{"nctId":"NCT00538850","phase":"PHASE3","title":"Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain","status":"COMPLETED","sponsor":"INSYS Therapeutics Inc","startDate":"2007-10","conditions":"Cancer","enrollment":130},{"nctId":"NCT00959764","phase":"PHASE3","title":"A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women","status":"COMPLETED","sponsor":"Tarsa Therapeutics, Inc.","startDate":"2009-06","conditions":"Osteoporosis, Postmenopausal","enrollment":565},{"nctId":"NCT01386333","phase":"PHASE1","title":"Safety Study of Intranasal Oxytocin in Frontotemporal Dementia","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2011-06","conditions":"Frontotemporal Dementia","enrollment":23}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"recentPublications":[{"date":"2022 Dec","pmid":"35749277","title":"Montgomery-Åsberg Depression Rating Scale factors in treatment-resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine.","journal":"International journal of methods in psychiatric research"},{"date":"2011 Nov-Dec","pmid":"21888757","title":"Efficacy and safety of fluticasone furoate nasal spray in Chinese adult and adolescent subjects with intermittent or persistent allergic rhinitis.","journal":"Allergy and asthma proceedings"},{"date":"2002 Dec","pmid":"12370798","title":"Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture.","journal":"Calcified tissue international"},{"date":"1999 May-Jun","pmid":"10389549","title":"Mometasone furoate nasal spray is rapidly effective in the treatment of seasonal allergic rhinitis in an outdoor (park), acute exposure setting.","journal":"Allergy and asthma proceedings"},{"date":"1999 Apr","pmid":"10227333","title":"Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.","journal":"Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"phase_3","status":"active","brandName":"Matching placebo nasal spray","genericName":"Matching placebo nasal spray","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}